(25 days)
The Hologic SecurView DX device is intended for selection, display, manipulation, filming and media interchange of multi-modality images from a variety of different modality systems. It also interfaces to various image storage and printing devices using DICOM or similar interface standards.
The device used with FDA cleared monitors may be used by a trained physician for display, manipulation and interpretation of lossless compressed or non-compressed mammographic images for screening and diagnostic mammography, as well as any other DICOM multi-modality image.
The Hologic Secur View DX is mainly a software product. It is used for visualization and manipulation of digital radiology images. The SecurView DX is a multi-modality review workstation software focused on mammographic applications. The software can drive at least two high-resolution gray scale displays (FDA cleared for Mammography), a PC mouse, a keyboard and an optional dedicated workflow keypad.
The software accepts standard or multi-frame mammography images that have been created according to the "FOR PRESENTATION" specification of the DICOM Standard with no compression or using lossless compression. Image processing is external to the SecurView DX software.
The software accepts multimodality images of US, MR, DR, CR, SC, CT, PET, and other DICOM formats for display and manipulation on the high resolution 5 MP gray scale displays or on a color 2 MP display in 2-D or 3-D view.
The SecurView DX software can be used in a single or in a multi-workstation configuration.
The minimum computer requirements to run the Secur View DX software are: Windows XP® Operating System Intel CPU with a clock rate of 2.0 GHz or greater 2.0 GB RAM or greater 140 GB Hard drive or greater, operating at 160 Mbs or greater CD-ROM/R 10/100 Base TX Network Interface
The provided document is a 510(k) summary for the Hologic SecurView DX, a software product for viewing and manipulating digital radiology images, primarily mammograms. The submission is a "Special 510(k)," meaning it's a modification to an already cleared device (K041555). Therefore, the study presented focuses on demonstrating substantial equivalence to the predicate device rather than establishing de novo performance criteria through a new clinical effectiveness study.
Here's an analysis of the requested information based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not specify quantitative acceptance criteria in the typical sense of a de novo device submission (e.g., specific sensitivity or specificity targets). Instead, the acceptance criterion for this Special 510(k) is substantial equivalence to its predicate device (SecurView DX K041555).
The reported device performance is demonstrated through its functional similarity and compliance with relevant standards.
| Acceptance Criterion | Reported Device Performance |
|---|---|
| Substantial Equivalence to predicate device (K041555) | - Maintains the same intended use. |
| - Similar computing requirements (CPU, RAM, Hard drive). | |
| - Compatible with the same network interface and peripheral devices (keyboard, workstation keypad, bar code reader). | |
| - Software developed under ISO 13485 and 21 CFR Part 820 Quality System. | |
| - Complies with ACR/NEMA DICOM Standard (PS 3.1-3.18 Set). | |
| - Displays and manipulates DICOM images for interpretation by trained personnel. | |
| - Functionality allows for recovery from partial/failed transmissions. | |
| - Incorporates passwords for security. | |
| - Hazards studied and controlled by a Risk Management Plan. | |
| - Differences are minor (e.g., Windows OS upgrade, DVD-R change, optional color display) and do not raise new questions of safety or effectiveness. |
2. Sample Size Used for the Test Set and Data Provenance
The document does not describe a specific test set or clinical study with patient data to evaluate diagnostic performance. As a Special 510(k) for a software modification, the focus is on verification and validation (V&V) of the software and hardware changes, demonstrating that the modified device performs as intended and is equivalent to the predicate. The "study" here is primarily an engineering and quality systems V&V process rather than a clinical trial.
Therefore, information on sample size, country of origin, or retrospective/prospective nature of a clinical test set is not provided because such a study was not deemed necessary for this type of submission.
3. Number of Experts Used to Establish Ground Truth and Their Qualifications
Since no clinical study with a test set of patient cases is described, there is no information provided on experts establishing ground truth for such a dataset. The "experts" involved would have been the Hologic engineering and quality assurance teams validating the software modifications.
4. Adjudication Method for the Test Set
As there is no described test set of patient cases, there is no adjudication method mentioned.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
The document does not report on a multi-reader multi-case (MRMC) comparative effectiveness study. The submission is a Special 510(k) focused on demonstrating substantial equivalence through software and hardware modifications, not on measuring the comparative effectiveness of human readers with or without AI assistance. The device itself is a viewing workstation, not an AI-assisted diagnostic tool.
6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study
The SecurView DX is a "Picture archiving and communication system" and a "multi-modality review workstation software." It is designed for "display, manipulation and interpretation of lossless compressed or non-compressed mammographic images using FDA cleared displays for screening and diagnostic mammography." This explicitly describes a human-in-the-loop device. Therefore, no standalone (algorithm-only) performance study was conducted or is relevant for this device's intended use.
7. Type of Ground Truth Used
Given that no clinical study with patient data is described, formal "ground truth" in the clinical sense (e.g., pathology, outcomes data) was not used for this submission to establish diagnostic accuracy. The ground truth for this submission relates to the functional correctness and compliance of the software and hardware modifications, established through internal testing, validation against DICOM standards, and verification against the predicate device's specifications.
8. Sample Size for the Training Set
No training set is mentioned because the SecurView DX is a software workstation for displaying and manipulating images, not a machine learning or AI algorithm that requires a training set of data.
9. How the Ground Truth for the Training Set Was Established
As there is no training set for an AI/ML algorithm mentioned, this information is not applicable.
{0}------------------------------------------------
Hologic, Inc. Special 510(k) for SecurView DX
Kob 2107
510(k) Summary SecurView DX
AUG 1 8 2006
Product Name: SecurView DX
Product Classification Name: Picture archiving and communication system
Product Classification Code: LLZ CFR Section: 892.2050
Classification Panel: Radiology Class II
Manufacturer: Hologic, Inc. 36 Apple Ridge Road Danbury, CT 06810 USA
- Contact Person: Gail Yaeker-Daunis Telephone Number: (203) 731-8337 Fax Number: (203) 731-8440
July 18, 2006 Date Prepared:
K041555 SecurView DX, Hologic Inc. Predicate Device:
Device Description: The Hologic Secur View DX is mainly a software product. It is used for visualization and manipulation of digital radiology images. The SecurView DX is a multi-modality review workstation software focused on mammographic applications. The software can drive at least two high-resolution gray scale displays (FDA cleared for Mammography), a PC mouse, a keyboard and an optional dedicated workflow keypad.
The software accepts standard or multi-frame mammography images that have been created according to the "FOR PRESENTATION" specification of the DICOM Standard with no compression or using lossless compression. Image processing is external to the SecurView DX software.
The software accepts multimodality images of US, MR, DR, CR, SC, CT, PET, and other DICOM formats for display and manipulation on the high resolution 5 MP gray scale displays or on a color 2 MP display in 2-D or 3-D view.
The SecurView DX software can be used in a single or in a multi-workstation configuration.
The minimum computer requirements to run the Secur View DX software are: Windows XP® Operating System Intel CPU with a clock rate of 2.0 GHz or greater 2.0 GB RAM or greater 140 GB Hard drive or greater, operating at 160 Mbs or greater
{1}------------------------------------------------
CD-ROM/R 10/100 Base TX Network Interface
Intended Use:
The Hologic SecurView DX is intended for selection, display, manipulation, filming and media interchange of multi-modality images from a variety of different modality systems. It also interfaces to various image storage and printing devices using DICOM or similar interface standards.
The device may be used by a trained physician for display, manipulation and interpretation of lossless compressed or non-compressed mammographic images using FDA cleared displays for screening and diagnostic mammography, as well as any other DICOM multi-modality image.
The Secur View DX software is typically used by trained professionals, including, but not limited to physicians, radiologists, nurses, medical technicians and assistants.
Comparison with Predicate Device:
The modified SecurView DX is substantially equivalent to the SecurView DX cleared August 9, 2004 as 510(k) #K041555 and has the same intended use as stated above,
| SecurView DX (K)041555 | SecurView DX Modified |
|---|---|
| Intel CPU with clock rate of 2.0 GHz orgreater | Same |
| 2.0 GB RAM or greater | Same |
| 140 GB Hard drive or greater operating at 160Mbs or greater | Same |
| CD ROM/read/write / DVD +/- read/write | CD ROM/R |
| Windows 2000 Operating System | Windows XP Operating System |
| US QWERTY Keyboard | Same |
| 10/100 Base TX Network Interface | 10/100 Base TX Network Interface |
| 3-button Mouse | Pointing Device w/wheel |
| Workstation Keypad | Workstation Keypad |
| (2) High-Resolution Grey Scale Display(FDA cleared for Mammography)21" Portrait Orientation,Resolution 2058/2560 pixels (5MP) | At least two High-Resolution GreyScale Displays (FDA cleared forMammography)Optional Color at least 2 MP, HighContrast Display for Multimodalityviewer |
{2}------------------------------------------------
| SecurView DX (K)041555 | SecurView DX Modified |
|---|---|
| Bar Code Reader (Code 39 Full ASCII, Code128, Code 39) | Same |
Software:
The SecurView DX software is specified, validated and tested by Hologic, Inc., under an ISO 13485 and 21 CFR Part 820 Quality System.
Safety and Effectiveness - Performance Standards:
The SecurView DX software is specified, validated and tested by Hologic, Inc., under a registered ISO 13485 and 21 CFR Part 820 Quality System.
The Secur View DX software complies with ACR/NEMA Digital Imaging Communications in Medicine version PS 3.1-3.18 (DICOM) Set
An Operator's Manual will be provided with each system that is user friendly and comprehensive, thus ensuring safe and effective operation.
Conclusion:
Similar to the predicate device, the SecurView DX software displays and manipulates DICOM images to be interpreted by a physician or trained medical personnel, providing ample opportunity for competent human intervention. The device and the predicate device share similar performance standards Device failures, which might result in partial or failed transmissions, images, or data, may be recovered from storage or retransmission after correcting the problem(s). Passwords are required for operation and to protect against unauthorized use. Potential hazards have been studied and controlled by a Risk Management Plan. Based on the information supplied in this 510(k), Hologic concludes that the device is substantially equivalent to the predicate device.
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" written around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread. The eagle is facing to the right.
Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850
AUG 1 8 2006
Ms. Gail Yeaker-Daunis Senior Regulatory Specialist Hologic, Inc. 36 Apple Ridge Rd. DANBURY CT 06810
Re: K062107
Trade/Device Name: SecurView DX Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: July 20, 2006 Received: July 24, 2006
Dear Ms. Yeaker-Daunis:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Image /page/3/Picture/10 description: The image is a black and white circular logo. The logo contains the text "1826-1926" at the top, followed by the letters "PA" in a bold, blocky font. Below the letters, the word "Centennial" is written in a smaller font. Three stars are arranged in a horizontal line at the bottom of the logo. The logo has a vintage or commemorative appearance.
Protecting and Promoting Public Health
{4}------------------------------------------------
Page 2 -
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 21 CFR 876.xxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|---|---|---|
| 21 CFR 884.xxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 894.xxx | (Radiology) | 240-276-0120 |
| Other | 240-276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150
or at its Internet address http://www.fda.gov/cdrlv/industry/support/index.l1tml.
Sincerely yours,
Nancy C. Hogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
Hologic, Inc. Special 510(k) for SecurView DX
K06 2167
510(k) No.
Indications For Use
Device Name: SecurView DX
The Hologic SecurView DX device is intended for selection, display, manipulation, filming and media interchange of multi-modality images from a variety of different modality systems. It also interfaces to various image storage and printing devices using DICOM or similar interface standards.
The device used with FDA cleared monitors may be used by a trained physician for display, manipulation and interpretation of lossless compressed or non-compressed mammographic images for screening and diagnostic mammography, as well as any other DICOM multi-modality image.
The SecurView DX is typically used by trained professionals, including, but not limited to physicians, radiologists, nurses, medical technicians and assistants.
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use21 CFR 801.109 | |
|---|---|
| OR | |
| Over-the-Counter Use |
(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
| 510(k) Number | K062102 |
|---|---|
| --------------- | --------- |
0131 11 11/2
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).